Marinus Pharmaceuticals Inc (MRNS)
Marinus Pharmaceuticals Market Cap: 73.06M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 73.06M |
May 16, 2024 | 71.41M |
May 15, 2024 | 73.06M |
May 14, 2024 | 73.61M |
May 13, 2024 | 74.16M |
May 10, 2024 | 73.06M |
May 09, 2024 | 76.08M |
May 08, 2024 | 78.56M |
May 07, 2024 | 86.25M |
May 06, 2024 | 81.30M |
May 03, 2024 | 82.95M |
May 02, 2024 | 79.65M |
May 01, 2024 | 80.75M |
April 30, 2024 | 77.45M |
April 29, 2024 | 76.90M |
April 26, 2024 | 77.18M |
April 25, 2024 | 78.00M |
April 24, 2024 | 79.10M |
April 23, 2024 | 79.10M |
April 22, 2024 | 81.02M |
April 19, 2024 | 75.80M |
April 18, 2024 | 77.45M |
April 17, 2024 | 79.10M |
April 16, 2024 | 65.92M |
April 15, 2024 | 71.41M |
Date | Value |
---|---|
April 12, 2024 | 413.08M |
April 11, 2024 | 435.05M |
April 10, 2024 | 444.39M |
April 09, 2024 | 460.32M |
April 08, 2024 | 450.43M |
April 05, 2024 | 428.46M |
April 04, 2024 | 476.80M |
April 03, 2024 | 477.90M |
April 02, 2024 | 487.24M |
April 01, 2024 | 492.73M |
March 28, 2024 | 493.97M |
March 27, 2024 | 483.59M |
March 26, 2024 | 480.31M |
March 25, 2024 | 487.96M |
March 22, 2024 | 481.40M |
March 21, 2024 | 492.33M |
March 20, 2024 | 493.97M |
March 19, 2024 | 508.18M |
March 18, 2024 | 492.88M |
March 15, 2024 | 513.09M |
March 14, 2024 | 489.05M |
March 13, 2024 | 515.83M |
March 12, 2024 | 507.08M |
March 11, 2024 | 463.37M |
March 08, 2024 | 483.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Pfizer Inc | 162.29B |
ACADIA Pharmaceuticals Inc | 2.444B |
Alnylam Pharmaceuticals Inc | 18.90B |
Regeneron Pharmaceuticals Inc | 108.23B |
Actinium Pharmaceuticals Inc | 291.88M |
Market Cap Related Metrics
PS Ratio | 2.586 |
PEG Ratio | -0.0015 |
Price | 1.33 |
Earnings Yield | -198.5% |
PEGY Ratio | -0.0015 |